Exit Readiness Checklist for Healthcare Portcos

Table of Contents

1. Introduction: Why Exit Readiness Matters for Healthcare Portcos
2. Financial & Operational Diligence
3. Technology & Platform Modernisation
4. Security, Compliance & Audit Readiness
5. AI & Automation Capability Rollout
6. Data Architecture & Clinical Integration
7. Vendor & Cost Optimisation
8. Talent & Leadership Alignment
9. Deal Documentation & Buyer Confidence
10. Exit Positioning & Valuation Uplift
11. 90-Day & 12-Month Action Plan
12. Summary & Next Steps

---

Introduction: Why Exit Readiness Matters for Healthcare Portcos {#introduction}

Healthcare portfolio companies face a unique exit challenge. Buyers—whether strategic acquirers, larger PE sponsors, or public-market candidates—conduct forensic diligence on three fronts: regulatory compliance, clinical/operational integrity, and technology capability. A 6–12 month exit preparation window can mean the difference between a 20% valuation uplift and a deal that stalls in due diligence or closes at a steep discount.

This checklist is built from real PE operating partner playbooks and real exits. It covers the operational, financial, technical, and compliance work that moves healthcare portcos from “ready to explore options” to “ready to win a competitive process.”

Unlike generic exit guides, this checklist is healthcare-specific. It assumes your portfolio company is a provider, payer, health-tech, or clinical-services business—and that your buyer will ask about HIPAA, clinical workflows, data governance, SOC 2 readiness, and your ability to scale without breaking regulatory guardrails.

---

Financial & Operational Diligence {#financial-operational}

Revenue Quality & Recurring Revenue Metrics

Buyers want to see clean, predictable revenue. This is non-negotiable in healthcare.

Audit your revenue recognition. Work with your CFO and external auditors to confirm that revenue is recorded in accordance with ASC 606 (or IFRS 15). In healthcare, this often means:

• Patient revenue (fee-for-service, capitated, or risk-bearing arrangements) is properly classified and collectible
• Payer contracts have clear terms and no hidden clawback or adjustment clauses
• Subscription or SaaS revenue is recognized over the contract term, not upfront
• Government reimbursement (Medicare, Medicaid) is properly accrued and provisioned

Buyers will stress-test your revenue base. Expect them to ask:

• What percentage of revenue is at-risk if a top 3 customer leaves?
• What is your patient/customer churn rate month-on-month and year-on-year?
• Are there any pending rate reductions or reimbursement changes?
• What is your cash-conversion cycle (days sales outstanding)?

If your top 3 customers represent >40% of revenue, you’ll face questions about concentration risk. If your churn rate is >5% per month, expect a valuation haircut. Start fixing this now.

EBITDA & Unit Economics

Healthcare buyers use EBITDA as the primary valuation lever. Multiples range from 6–15x EBITDA depending on growth, margins, and regulatory risk.

Normalise your EBITDA. This means:

• Removing one-time costs (restructuring, legal, integration)
• Adjusting for owner perks or non-recurring compensation
• Backing out stock-based compensation (if applicable)
• Normalising for seasonal or cyclical revenue

Work with your CFO and controller to build a detailed EBITDA bridge for the past 3 years and a forward-looking normalised EBITDA for the next 12 months. Buyers will ask about this relentlessly.

Unit economics matter. In healthcare, this means:

• Cost per patient visit or admission
• Cost per claim processed (if you’re a payer or claims management company)
• Lifetime value to customer acquisition cost (LTV:CAC) ratio
• Gross margin by service line or product

If you’re a clinical services business, your labour costs are your largest lever. If you’re a health-tech platform, your cloud and infrastructure costs matter. Map these carefully and identify where you have room to improve before the exit process.

Working Capital & Cash Flow

Healthcare businesses are often working-capital intensive. Patient revenue may be delayed 30–90 days. Payer reimbursement can take 60+ days. Inventory (for medical devices or supplies) ties up cash.

Model your cash cycle. Create a 13-week cash flow forecast and a full-year forecast for the next 2 years. Include:

• Days sales outstanding (DSO) for patient and payer revenue
• Days inventory outstanding (DIO) for any physical inventory
• Days payable outstanding (DPO) for supplier payments
• Payroll cycles and tax payments
• Debt service and capital expenditure

Buyers will ask: “If we acquire you, what working capital do we need to inject to keep the lights on?” A clean cash model shows you’ve thought this through and that you’re not hiding cash-flow surprises.

Operational KPIs & Benchmarking

Buyers want to see that your operations are efficient compared to peers. In healthcare, this often means:

• For providers: patient volume, average length of stay, readmission rates, bed utilisation, staff-to-patient ratios
• For payers: medical loss ratio (MLR), administrative expense ratio (AER), claims processing time, network adequacy
• For health-tech: user adoption, feature utilisation, support ticket volume, system uptime, data accuracy

Gather your operational KPIs for the past 3 years. Compare yourself to published benchmarks (via MGMA, HFMA, or industry reports). If you’re below benchmark, have a plan to improve. If you’re above, highlight it loudly.

---

Technology & Platform Modernisation {#technology-platform}

Legacy System Assessment & Modernisation Roadmap

One of the first questions a buyer asks: “What’s your tech stack, and how long until it becomes a liability?”

Healthcare is notorious for legacy systems. Many providers still run 15+ year-old EHRs. Many payers run 20+ year-old claims systems. These systems are often fragile, expensive to maintain, and a drag on growth.

Conduct a technology audit. Document:

• Core systems: EHR, claims management, billing, patient portal, analytics
• Integration layer: How do systems talk to each other? (HL7, FHIR, custom APIs, batch files?)
• Infrastructure: On-premise, cloud, hybrid? Containerised or monolithic?
• Technical debt: Known bugs, performance issues, security vulnerabilities, outdated libraries
• Maintenance burden: How many engineers are tied up keeping the lights on vs. building new features?

Then, build a 3-year modernisation roadmap. This doesn’t mean rip-and-replace (too risky in healthcare). It means:

• Identifying which systems can be replaced with modern SaaS (e.g., moving from legacy EHR to a cloud-based alternative)
• Building modern APIs and integration layers to connect legacy and new systems
• Containerising and migrating workloads to cloud where possible
• Automating manual, repetitive processes

A credible modernisation roadmap shows buyers you’ve thought about the future and that you’re not asking them to inherit a 20-year-old technical nightmare.

Platform Engineering & Scalability

If your business has a software component (which most healthcare businesses do), buyers will stress-test your ability to scale.

Assess your platform architecture:

• Can your system handle 2x, 5x, or 10x current load without re-engineering?
• Are you single-tenant or multi-tenant? (Multi-tenant is more valuable and scalable.)
• Is your database properly indexed and optimised?
• Do you have proper monitoring, logging, and alerting in place?
• What is your system uptime? (Anything <99.5% is a red flag in healthcare.)

Work with your CTO or head of engineering to build a scalability roadmap. This might involve:

• Database optimisation and sharding
• Microservices architecture (if you’re still monolithic)
• Caching and CDN strategies
• Load testing and capacity planning

A scalable, modern platform is worth a 20–30% valuation premium. A fragile, legacy platform is worth a 20–30% discount. The difference is often 6–12 months of focused engineering work.

Cloud Migration & Infrastructure Modernisation

Most healthcare buyers prefer cloud-native or cloud-hybrid architectures. On-premise-only infrastructure raises questions about scalability, disaster recovery, and cost.

Plan your cloud strategy:

• If you’re on-premise, identify which workloads can move to cloud (AWS, Azure, GCP) without compromising HIPAA compliance
• If you’re hybrid, document your rationale for what stays on-premise and why
• If you’re cloud-native, document your architecture, backup strategy, and disaster recovery plan

Work with a platform engineering partner if needed. In healthcare, cloud migration is not just about moving VMs—it’s about re-architecting for HIPAA, ensuring data residency and encryption, and building proper audit trails.

PADISO helps healthcare companies modernise their infrastructure through platform development in Boston and platform development in Sydney with GxP and HIPAA-aware architecture. If you need fractional technical leadership to oversee this work, consider a fractional CTO advisory in Boston or fractional CTO advisory in Sydney to guide the modernisation process.

---

Security, Compliance & Audit Readiness {#security-compliance}

SOC 2 & ISO 27001 Compliance

If your business is a SaaS platform, health-tech vendor, or any business that processes healthcare data on behalf of customers, SOC 2 Type II certification is table stakes. ISO 27001 is increasingly expected by larger buyers and enterprise customers.

SOC 2 readiness checklist:

• Do you have documented security policies and procedures?
• Do you have access controls (role-based access control, multi-factor authentication)?
• Do you encrypt data in transit and at rest?
• Do you have a vulnerability management program (regular scanning, patching, penetration testing)?
• Do you have incident response and business continuity plans?
• Do you have employee security training and background checks?
• Do you have a third-party risk management program (vendor assessments)?

If you’re not SOC 2 compliant, you’re leaving money on the table. Enterprise customers (and buyers) will ask for it. Getting to SOC 2 Type II typically takes 6–12 months if you’re starting from scratch.

PADISO’s security audit service helps healthcare and tech companies get audit-ready in weeks, not months, using Vanta for SOC 2, ISO 27001, and GDPR compliance. This is a concrete way to accelerate your readiness and show buyers you’re serious about security.

HIPAA Compliance & Business Associate Agreements

If you handle Protected Health Information (PHI), HIPAA compliance is non-negotiable. Buyers will audit this relentlessly.

HIPAA readiness checklist:

• Do you have a HIPAA Security Officer and Privacy Officer?
• Do you have a Business Associate Agreement (BAA) with all upstream and downstream partners?
• Do you have a Security Risk Analysis (SRA) on file?
• Do you have policies and procedures for access control, audit logging, encryption, and breach notification?
• Do you have employee training records and signed confidentiality agreements?
• Do you have a Disaster Recovery and Business Continuity plan tested at least annually?
• Have you conducted a HIPAA compliance audit in the past 12 months?

If you’re missing any of these, start now. HIPAA violations can result in fines ($100–$50,000 per violation) and can tank a deal.

State & Federal Regulatory Compliance

Healthcare is heavily regulated at both state and federal levels. Depending on your business model, you may need to comply with:

• Stark Law & Anti-Kickback Statute (AKS): If you’re a provider or vendor, you need to ensure your relationships with physicians and hospitals don’t violate these laws
• State licensing: Many healthcare businesses need state licenses (medical, nursing, pharmacy, etc.)
• State telehealth regulations: If you offer telehealth, each state has different requirements
• State insurance regulations: If you’re a payer or insurance-adjacent, state insurance commissioners oversee you
• FDA regulations: If you’re a medical device or diagnostic company, you may need FDA clearance or approval

Work with healthcare legal counsel to audit your compliance posture. Document any compliance issues and your remediation plan. Buyers will ask.

Data Privacy & Third-Party Risk Management

Beyond HIPAA, you need to manage data privacy and third-party risk.

Data privacy checklist:

• Do you have a Data Privacy Policy that’s clear and compliant with GDPR, CCPA, and state privacy laws?
• Do you have a Data Processing Agreement (DPA) with all data processors?
• Do you have a process for handling data subject access requests (DSARs) and deletion requests?
• Do you have a data retention and disposal policy?

Third-party risk checklist:

• Do you have a vendor assessment process (security questionnaires, SOC 2 reviews, etc.)?
• Do you have contracts with all vendors that include data protection and indemnification clauses?
• Do you monitor your vendors for security incidents and compliance issues?
• Do you have a process for offboarding vendors and ensuring data is properly deleted?

Third-party risk is increasingly important. If one of your vendors gets breached and your data is exposed, you’re liable. Buyers will ask about your vendor management program.

---

AI & Automation Capability Rollout {#ai-automation}

AI Readiness Assessment

AI is no longer optional in healthcare. Buyers expect portfolio companies to have a clear AI strategy and to be actively deploying AI in operations, clinical workflows, and customer-facing products.

AI readiness assessment:

• Do you have a Chief AI Officer or someone accountable for AI strategy?
• Do you have a data and AI governance framework (model inventory, explainability, bias testing)?
• Do you have quality data (clean, labelled, representative) to train models on?
• Do you have the talent (data scientists, ML engineers) to build and maintain models?
• Do you have infrastructure (GPU, data pipelines) to support AI workloads?
• Do you have a process for testing, validating, and deploying models safely in healthcare settings?

If you’re weak in any of these areas, start addressing it now. AI is a valuation lever. Companies with credible AI capabilities command 15–25% premiums.

Workflow Automation & Agentic AI

One of the fastest ways to improve margins and unlock value is workflow automation. In healthcare, this often means:

• Claims processing: Automating claim validation, coding, and submission
• Prior authorisation: Automating the prior auth workflow to reduce denial rates and speed up approvals
• Patient scheduling: Automating appointment scheduling, reminders, and no-show management
• Clinical documentation: Automating clinical note generation and coding from voice or EHR data
• Revenue cycle: Automating billing, collections, and accounts receivable

Agentic AI (AI systems that can autonomously execute workflows with human oversight) is particularly valuable in healthcare. A claims processing agent that can validate, code, and submit claims with 95%+ accuracy can reduce manual FTE by 30–50%.

Start by identifying 2–3 high-impact workflows that are labour-intensive and rule-based. Pilot agentic AI on these workflows. Measure the impact (time saved, cost reduced, accuracy improved). Then scale to other workflows.

PADISO’s AI & Agents Automation service helps healthcare and other portfolio companies deploy agentic AI to automate workflows and unlock cost savings. If you need fractional CTO guidance on AI strategy, consider fractional CTO advisory in Houston or fractional CTO advisory in Melbourne to help you scope and execute AI rollout.

Clinical AI & Evidence-Based Deployment

If you’re deploying AI in clinical settings (diagnostic AI, treatment recommendation engines, risk prediction models), buyers will scrutinise your evidence base and validation approach.

Clinical AI checklist:

• Do you have peer-reviewed publications or clinical evidence supporting your AI model’s performance?
• Have you validated your model on diverse patient populations (age, gender, race, comorbidities)?
• Have you tested for bias and fairness (does the model perform equally well across patient groups)?
• Do you have a process for monitoring model performance in production (model drift detection)?
• Do you have a process for updating and retraining models as new data becomes available?
• Do you have clinician workflows and decision support (is the model integrated into the clinical workflow, or is it a black box)?
• Do you have informed consent and transparency (do patients/clinicians know they’re interacting with an AI system)?

Clinical AI is high-reward but also high-risk. If your model fails or causes harm, you’re liable. Buyers will want to see rigorous validation and governance.

---

Data Architecture & Clinical Integration {#data-architecture}

Data Governance & Master Data Management

Clean data is the foundation of everything: accurate billing, reliable analytics, trustworthy AI, and regulatory compliance.

Data governance checklist:

• Do you have a Chief Data Officer or Data Governance Officer accountable for data quality?
• Do you have a data dictionary (metadata) that documents all key data elements, definitions, and ownership?
• Do you have data quality metrics (completeness, accuracy, timeliness, consistency)?
• Do you have a data quality dashboard that tracks these metrics in real-time?
• Do you have a process for identifying and remediating data quality issues?
• Do you have master data management (MDM) for key entities (patients, providers, claims, etc.)?

If your data is messy, your analytics will be unreliable, your AI models will be biased, and your billing will be inaccurate. Start with a data audit. Identify your most critical data elements (patient ID, claim status, clinical codes, etc.). Assess their quality. Build a remediation plan.

Clinical Data Integration & Interoperability

Healthcare data lives in silos. Patients have records in multiple EHRs. Claims data is in separate systems. Lab and imaging data are in separate systems. Integrating this data is complex but valuable.

Data integration strategy:

• Identify key data sources (EHR, billing, lab, imaging, claims, pharmacy, etc.)
• Choose an integration approach: HL7 v2 (legacy), FHIR (modern), custom APIs, or middleware platforms
• Build a data warehouse or data lake that consolidates data from all sources
• Implement ETL (extract, transform, load) pipelines to keep data in sync
• Implement data quality checks at each step

FHIR (Fast Healthcare Interoperability Resources) is the modern standard. If you’re building new integrations, use FHIR. If you’re maintaining legacy HL7 v2 integrations, plan to migrate to FHIR over time.

PADISO helps healthcare companies build HIPAA-aware data platforms and clinical integration. Platform development in Philadelphia and platform development in San Diego are examples of healthcare-focused platform work that includes HIPAA pipelines and clinical integration.

Analytics & Embedded Reporting

Buyers want to see that you’re generating insights from your data. This means analytics and reporting.

Analytics checklist:

• Do you have a business intelligence (BI) platform (Tableau, Looker, Superset, etc.)?
• Do you have dashboards that track key operational metrics (volume, revenue, cost, quality, patient satisfaction)?
• Do you have dashboards that track financial metrics (EBITDA, margins, working capital, cash flow)?
• Do you have ad-hoc reporting capabilities so stakeholders can answer their own questions?
• Do you have data governance around BI (who can access what data, how is data defined)?

Many healthcare companies have BI platforms but they’re poorly maintained, poorly documented, and underutilised. Start by auditing your BI platform. Identify which dashboards are actually used. Retire the ones that aren’t. Improve the ones that are.

Then, build dashboards that matter to buyers: revenue quality, unit economics, operational efficiency, and financial health. These are the metrics that drive valuation.

---

Vendor & Cost Optimisation {#vendor-cost}

Vendor Rationalization & Consolidation

Most healthcare companies have too many vendors. You might have 50+ vendors for software, services, and infrastructure. This creates complexity, cost, and risk.

Vendor audit:

• List all vendors and annual spend
• Categorise by function (software, infrastructure, services, etc.)
• Identify overlaps (multiple vendors doing the same thing)
• Identify underutilised vendors (paying for something you don’t use)
• Assess vendor health (are they stable, financially healthy, compliant)?

Then, consolidate. Eliminate overlaps. Renegotiate contracts with key vendors. Move to fewer, larger vendors where possible (better pricing, better support, less complexity).

A typical healthcare company can save 15–25% on vendor spend through rationalisation. That’s pure EBITDA uplift.

Cloud Cost Optimisation

If you’re on cloud (AWS, Azure, GCP), you’re probably overspending. Most companies waste 20–40% of their cloud spend.

Cloud cost optimisation:

• Audit your cloud spend by service, project, and team
• Identify unused resources (unattached storage, idle compute, etc.) and delete them
• Right-size instances (are you running oversized instances that could be smaller)?
• Use reserved instances or savings plans for predictable workloads
• Use spot instances for non-critical, interruptible workloads
• Optimise data transfer costs (egress fees can be significant)
• Implement tagging and cost allocation so teams understand their spend

A typical company can save 20–30% on cloud costs through these optimisations. That’s another 1–2% of revenue in EBITDA uplift.

Software License Optimization

Software licenses are often a major cost category in healthcare (EHR, billing, analytics, etc.). Many companies have too many licenses or are paying for licenses they don’t use.

License audit:

• Audit all software licenses (count, cost, usage)
• Identify unused or underutilised licenses
• Negotiate volume discounts with key vendors
• Consider open-source alternatives for some tools
• Implement license compliance (ensure you’re not over-using licenses)

A typical company can save 10–20% on software costs through rationalisation.

---

Talent & Leadership Alignment {#talent-leadership}

Executive Team & Bench Strength

Buyers want to see a strong, stable executive team. Turnover in the C-suite is a red flag.

Executive team assessment:

• Do you have a full executive team (CEO, CFO, COO, CTO, CMO, etc.)?
• Are your executives experienced in healthcare?
• Are your executives aligned on strategy and vision?
• What is your executive turnover rate (should be <10% annually)?
• Do you have succession plans for key roles?
• Are your executives being retained post-acquisition (retention is a deal lever)?

If you’re missing key executives (especially a CFO or CTO), hire now. If your executives are misaligned, get aligned. If you have high turnover, understand why and fix it.

For fractional CTO support, PADISO offers fractional CTO advisory in New York and other locations to provide technical leadership and help with technology strategy, hiring, and vendor decisions.

Engineering & Technical Talent

For healthcare companies with significant software/tech components, engineering talent is critical.

Engineering team assessment:

• How many engineers do you have? What’s your engineer-to-user ratio (benchmark: 1 engineer per 100–500 users depending on product complexity)?
• What’s your engineer retention rate? (Should be >90% annually)
• What’s your hiring pipeline? (Can you hire more engineers if you need to scale)?
• Do you have a mix of seniority levels (junior, mid, senior, staff)?
• Are your engineers trained in healthcare compliance (HIPAA, HITRUST, etc.)?
• Do you have a process for code review, testing, and deployment?

If your engineering team is small or junior, consider bringing in fractional CTO support to mentor and guide. If you’re losing engineers, understand why and fix it.

Organisational Design & Scalability

Your organisation should be designed to scale. If you’re at 100 people and want to get to 500, your org structure needs to support that.

Organisational design checklist:

• Do you have clear reporting lines and accountability?
• Do you have functional leaders (Finance, Operations, Engineering, Sales, Marketing) accountable for their areas?
• Do you have documented processes and playbooks so people know how to do their jobs?
• Do you have a culture and values that attract and retain talent?
• Do you have a compensation philosophy that’s competitive and fair?
• Do you have a performance management process (goal-setting, feedback, development)?

If your org is ad-hoc or unclear, buyers will worry about your ability to scale. Spend time on organisational design.

---

Deal Documentation & Buyer Confidence {#deal-documentation}

Financial Statements & Audit Trail

Buyers will want audited or reviewed financial statements. If you don’t have them, get them.

Financial documentation checklist:

• Do you have audited or reviewed financial statements for the past 3 years?
• Do you have monthly management accounts (P&L, balance sheet, cash flow)?
• Do you have a detailed general ledger with proper account codes and documentation?
• Do you have supporting schedules for key balance sheet items (AR, AP, inventory, debt, equity)?
• Do you have a detailed revenue recognition policy and supporting documentation?
• Do you have a detailed EBITDA bridge and normalisation schedule?

If you don’t have audited statements, get them. If your monthly accounts are late or inaccurate, fix it. If your general ledger is a mess, clean it up.

Regulatory & Compliance Documentation

Buyers will want evidence of your compliance posture.

Compliance documentation checklist:

• Do you have a HIPAA Security Risk Analysis (SRA)?
• Do you have signed Business Associate Agreements (BAAs) with all upstream and downstream partners?
• Do you have SOC 2 Type II audit report (or a plan to get one)?
• Do you have documented security policies and procedures?
• Do you have evidence of employee training and background checks?
• Do you have incident response and breach notification documentation?
• Do you have regulatory correspondence (FDA, state licensing, etc.)?

If you’re missing any of these, start gathering them now. If you don’t have SOC 2, work with a partner like PADISO to get security audit ready in weeks using Vanta.

Technology & Architecture Documentation

Buyers will want to understand your tech stack and architecture.

Tech documentation checklist:

• Do you have a system architecture diagram (what systems do you have, how do they connect)?
• Do you have a technology roadmap (what are you building in the next 12–24 months)?
• Do you have documentation of your infrastructure (cloud, on-premise, hybrid)?
• Do you have a list of all third-party services and integrations?
• Do you have documentation of your data flows (where data comes from, where it goes, how it’s processed)?
• Do you have documentation of your security controls (encryption, access control, audit logging)?

If you don’t have these, work with your CTO or engineering team to document them. It doesn’t need to be fancy—a simple architecture diagram and a list of systems goes a long way.

Customer & Contract Documentation

Buyers will want to understand your customer base and contract terms.

Customer documentation checklist:

• Do you have a customer list with annual contract value (ACV), contract term, and renewal date?
• Do you have a detailed contract review (are there unusual terms, clawback clauses, termination provisions)?
• Do you have a customer health assessment (which customers are at risk of churning)?
• Do you have customer satisfaction data (NPS, CSAT, reference-ability)?
• Do you have a customer concentration analysis (what percentage of revenue is at-risk)?

Buyers will stress-test your customer base. Be transparent about customer health and concentration risk. If you have a customer concentration issue, have a plan to diversify.

---

Exit Positioning & Valuation Uplift {#exit-positioning}

Valuation Drivers in Healthcare M&A

Healthcare M&A multiples vary widely based on business model, growth, margins, and risk. Understanding what drives valuation in your segment is critical.

Key valuation drivers:

• Revenue growth: Higher growth = higher multiple. A 30% YoY growth company might trade at 8–10x EBITDA, while a 5% growth company might trade at 4–6x EBITDA
• EBITDA margins: Higher margins = higher multiple. A 40% EBITDA margin company might trade at 10–12x, while a 15% margin company might trade at 5–7x
• Revenue quality: Recurring, predictable revenue = higher multiple. Subscription or capitated revenue is worth more than transactional revenue
• Customer concentration: Lower concentration = higher multiple. If your top 3 customers are <30% of revenue, you get a premium
• Regulatory risk: Lower risk = higher multiple. A company with clean compliance is worth more than one with regulatory issues
• Technology: Modern, scalable technology = higher multiple. A company with a modern platform is worth more than one with legacy systems
• Market position: Market leadership = higher multiple. A market-leading company commands a premium
• Talent & team: Strong team = higher multiple. A company with low turnover and strong leadership gets a premium

Work backwards from valuation drivers. If you’re weak on growth, focus on growth. If you’re weak on margins, focus on cost reduction and pricing. If you’re weak on technology, focus on modernisation.

Buyer Personas & Strategic Rationale

Different buyers have different priorities. Understanding who might buy you and what they value helps you position yourself.

Potential buyer personas:

• Larger healthcare provider/system: Values revenue synergies (cross-selling, consolidation), cost synergies (procurement, shared services), and clinical integration
• Healthcare PE sponsor: Values EBITDA growth (cost reduction, revenue synergies), operational improvements, and add-on acquisition opportunities
• Strategic acquirer (tech company): Values technology, data, talent, and customer relationships
• Public company: Values earnings accretion, strategic fit, and low integration risk

For each potential buyer persona, tailor your story. What do they care about? What problems do you solve for them? What synergies do you create?

Competitive Process & Deal Structure

A competitive process (multiple bidders) typically results in a 15–25% higher valuation than a single bidder.

Competitive process checklist:

• Do you have a compelling investment thesis and story that multiple buyers would find attractive?
• Do you have clean financials and documentation that allow buyers to move quickly through diligence?
• Do you have a data room with all key documents organised and accessible?
• Do you have a management presentation that clearly articulates your value proposition?
• Do you have a process (teaser, CIM, management meetings, final bids) that creates urgency and competition?

Work with your investment banker or advisor to design a competitive process. The goal is to create multiple interested buyers and drive them to bid against each other.

Earnout & Retention Structures

Many healthcare deals use earnouts (where part of the purchase price is contingent on hitting future targets) and retention structures (where key executives are retained post-close).

Earnout & retention strategy:

• Are you willing to take an earnout (lower upfront price, higher potential payout if you hit targets)?
• What metrics would the earnout be based on (revenue, EBITDA, customer retention, clinical outcomes)?
• How long would the earnout period be (typically 1–3 years)?
• Which key executives would be retained post-close and for how long?
• What retention incentives (bonuses, equity) would you offer?

Earnouts can be a double-edged sword. They allow you to capture upside if you hit targets, but they also mean you’re still involved post-close and there’s execution risk. Think carefully about your earnout strategy.

---

90-Day & 12-Month Action Plan {#action-plan}

90-Day Quick Wins

If you’re 6–12 months away from an exit, focus on quick wins that improve valuation without requiring major structural changes.

90-day priorities:

1. Financial cleanup (2 weeks): Audit revenue recognition, normalise EBITDA, build a detailed financial model
2. Vendor rationalisation (2 weeks): Audit vendors, identify overlaps and underutilised vendors, start renegotiations
3. Data room setup (1 week): Create a virtual data room and start populating it with key documents
4. Compliance documentation (3 weeks): Gather HIPAA, SOC 2, regulatory documentation; identify gaps
5. Customer concentration review (1 week): Analyse customer base, identify concentration risk, develop diversification plan
6. Tech documentation (2 weeks): Create architecture diagrams, tech roadmap, infrastructure documentation
7. Executive alignment (ongoing): Ensure executive team is aligned on exit strategy and timeline
8. Messaging & positioning (2 weeks): Develop investment thesis, buyer personas, and talking points

These 90 days should result in 2–5% EBITDA uplift (from vendor rationalisation and cost reduction) and significantly improved buyer confidence.

12-Month Transformation Plan

If you have 12 months, you can drive more substantial improvements.

12-month priorities:

1. Revenue growth & quality (ongoing): Focus on high-quality, recurring revenue; reduce customer concentration
2. Margin improvement (ongoing): Cost reduction, operational efficiency, automation
3. Technology modernisation (3–6 months): Cloud migration, platform engineering, legacy system replacement
4. AI & automation rollout (6–12 months): Identify high-impact workflows, pilot agentic AI, measure and scale
5. Compliance & security (3–6 months): SOC 2 certification, HIPAA audit, data governance
6. Data integration & analytics (6–12 months): Build data warehouse, integrate clinical data, develop BI dashboards
7. Talent & organisation (ongoing): Hire key executives, build bench strength, design scalable org
8. Competitive process preparation (ongoing): Develop data room, management presentation, process design

A well-executed 12-month plan can result in 15–30% EBITDA uplift and 20–40% valuation uplift.

---

Summary & Next Steps {#summary}

Exit readiness for healthcare portcos is not a one-time checklist. It’s a 6–12 month journey of financial cleanup, operational improvement, technology modernisation, and compliance hardening.

The companies that exit successfully are the ones that:

1. Get their financials right. Clean revenue recognition, normalised EBITDA, and clear unit economics
2. Modernise their technology. Cloud-native architecture, scalable platforms, modern integrations
3. Harden their compliance. SOC 2, HIPAA, data governance, security controls
4. Deploy AI & automation. Workflow automation, cost reduction, operational efficiency
5. Optimise their costs. Vendor rationalisation, cloud cost optimisation, software license management
6. Build a strong team. Experienced executives, bench strength, low turnover
7. Tell a compelling story. Clear investment thesis, buyer personas, competitive positioning

If you’re a PE operating partner managing healthcare portcos, start with this checklist. Identify your 2–3 biggest gaps. Build a 90-day plan to address them. Then build a 12-month transformation plan to drive substantial improvement.

For technical leadership and platform modernisation, consider engaging a partner like PADISO. Whether you need fractional CTO advisory in Melbourne for strategic guidance, platform development in Toronto for architecture and engineering, or security audit services to accelerate SOC 2 and ISO 27001 compliance, having experienced partners can significantly accelerate your exit readiness.

For legal and regulatory guidance, consult with healthcare-focused advisors. The American Bar Association’s exit planning resources and American Health Law Association practice areas are valuable references for healthcare-specific exit considerations.

For general M&A and deal preparation, resources from KPMG, PwC, Deloitte, EY, and BDO provide broader context on deal preparation, financial readiness, and buyer expectations.

For healthcare-specific M&A diligence, Mercer’s healthcare M&A due diligence resources offer insights into the unique diligence themes that matter in healthcare transactions.

Your next step: Schedule a call with your CFO, CTO, and board. Review this checklist. Identify your top 5 gaps. Build a 90-day action plan. Then execute relentlessly. Exit readiness is a muscle—the more you focus on it, the stronger your position becomes.

The difference between a company that exits at 6x EBITDA and one that exits at 8x EBITDA is often 6–12 months of focused preparation. Start now.